FDA Approves UniQure's Hemgenix, First Hemophilia B Gene Therapy For Adults
November 23, 2022 at 08:12 AM EST
UniQure N.V.'s(NASDAQ: QURE) partnerCSL Limited(OTC: CSLLY) hasreceived FDA approvalfor Hemgenix ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.